Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
RecruitingNCT05968703Phase: NAStarted 2025-04-08
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of a novel deep brain stimulation (DBS) of the Subthalamic Nucleus (STN) and Nucleus Basalis of Meynert (NBM) to treat cognit
Eligibility
Sex
ALL
Min Age
21 Years
Max Age
80 Years
Locations
Stanford Neuroscience Health CenterStanford, California, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05968703